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Abstract: Acute kidney injury (AKI) after cardiac surgery is a
common and serious complication. Although lower than normal serum
bicarbonate levels are known to be associated with consecutive renal
function deterioration in patients with chronic kidney injury, it is not
well-known whether preoperative low serum bicarbonate levels are
associated with the development of AKI in patients who undergo cardiac
surgery. Therefore, the clinical implication of preoperative serum
bicarbonate levels on AKI occurrence after cardiac surgery was inves-
tigated. Patients who underwent coronary artery bypass or valve surgery
at Yonsei University Health System from January 2013 to December
2014 were enrolled. The patients were divided into 3 groups based on
preoperative serum bicarbonate levels, which represented group 1
(below normal levels) <23mEq/L; group 2 (normal levels) 23 to
24mEq/L; and group 3 (elevated levels) >24mEq/L. The primary
outcome was the predicated incidence of AKI 48 hours after cardiac
surgery. AKI was defined according to Acute Kidney Injury Network
criteria. Among 875 patients, 228 (26.1%) developed AKI within
48 hours after cardiac surgery. The incidence of AKI was higher in
group 1 (40.9%) than in group 2 (26.5%) and group 3 (19.5%)
(P< 0.001). In addition, the duration of postoperative stay in a hospital
intensive care unit (ICU)was longer for AKI patients and for those in the
low-preoperative-serum-bicarbonate-level groups. A multivariate logis-
tic regression analysis showed that low preoperative serum bicarbonate
levels were significantly associated with AKI even after adjustment for
age, sex, hypertension, diabetes mellitus, operation type, preoperative
hemoglobin, and estimated glomerular filtration rate. In conclusion, low
serum bicarbonate levels were associated with higher incidence of AKI
and prolonged ICU stay. Further studies are needed to clarify whether
strict correction of bicarbonate levels close to normal limits may have a
protective role in preventing further AKI development.
(Medicine 95(13):e3216)MD, Jong Hyun Jh g Jung Oh, MD,
MD, PhD, and Shin-Wook Kang, MD, PhD
AKI, eGFR = estimated glomerular filtration rate, ICU = intensive
care unit, RRT = renal replacement therapy.
INTRODUCTION
A cute kidney injury (AKI) is a common postoperative com-plication in patients undergoing cardiac surgery. The inci-
dence rates of cardiac surgery-associated AKI (CSA-AKI) have
been reported to be 7.7% to 40% depending on patient popu-
lations,1–5 and CSA-AKI significantly increases mortality
risk.3,6,7 In addition, patients who develop CSA-AKI frequently
require renal replacement therapy (RRT), which lengthens ICU
stay and worsens long-term morbidity.3 Mild deterioration in
renal function after cardiac surgery not requiring RRT is also
significantly associated with poor clinical outcome.8
Several factors have been found responsible for the devel-
opment of CSA-AKI, including generation of reactive oxygen
species, inflammatory cytokines, and ischemia-reperfusion
injury.9–11 Even though the pathogenesis of CSA-AKI is not
fully understood, it seems to be a multifactorial interaction
between hemodynamic, inflammatory, and direct nephrotoxic
injuries to renal cells.
Acidosis has been considered to be implicated in the
pathogenesis of renal injury. It could aggravate tubular damage
by increasing tubular ammonia production, which activates the
complement system and leads to tubulointerstitial injury.12,13
Moreover, activation of the intrarenal renin–angiotensin system
was observed in mice with acid overload.14 Furthermore,
several observational studies have shown a clear relationship
between metabolic acidosis and rapid decline in renal function
in patients with early or advanced chronic kidney disease
(CKD).15–19 There was also a significant association of acidosis
with all-cause mortality in patients with CKD.20–22 However,
the impact of serum bicarbonate levels on the development of
CSA-AKI has not yet been fully elucidated. In this study, we
aimed to explore the clinical implication of preoperative serum
bicarbonate levels in the development of AKI after cardiac
surgery.
MATERIALS AND METHODS
Patient Selection and Outcome
Data were retrieved based on the medical records of 994
patients who underwent coronary artery bypass graft (CABG) or
valve surgery at Yonsei University Health System in Seoul from
January 2013 to December 2014. Patients were excluded if they
met the following criteria: <18 years of age, history of hemo-
dialysis or peritoneal dialysis before surgery, and incomplete
data. Thus, a total of 875 patients were included in the finaltocol was approved by the Institutional
ei University Health System (Approval
. Because the present study was a
www.md-journal.com | 1
retrospective, medical-record-based study and the study sub-
jects were de-identified, the board waived the need for written
consent from the patients.
Laboratory and Clinical Data
Demographic and clinical data at the time of surgery—
including age, sex, comorbidities, and type of operation—were
recorded. Total serum carbon dioxide levels, which are gener-
ally used as indirect measures of serum bicarbonate concen-
trations, were determined by an electrode-based method
(UniCel DxC 800; Beckman Coulter, Inc, Brea, CA). Labora-
tory data measured within 96 hours before operation were
adopted for preoperative values. The following biochemical
laboratory test results were also collected: hemoglobin, serum
creatinine, glucose, total cholesterol, and albumin levels. The
estimated glomerular filtration rate (eGFR) was calculated
using the 4-variable Modification of Diet in Renal Disease
Study equation.23
Follow-Up and Endpoints
All patients were followed up until hospital discharge after
operation. The patients were divided into 3 groups based on
preoperative serum bicarbonate levels, which represented group
1 (below normal levels)<23mEq/L; group 2 (normal levels) 23
to 24mEq/L; and group 3 (elevated levels) >24mEq/L. The
primary outcome was the development of AKI within 48 hours
after cardiac surgery. AKI was defined according to Acute
Kidney Injury Network (AKIN) criteria: stage 1, an increase
in serum creatinine 26.5mmol/L (0.3mg/dL) or increase to
150% and 199% (1.5- to 1.9-fold) from baseline; stage 2, an
increase in serum creatinine to 200% to 299% (>2- to 2.9-fold)
from baseline; and stage 3, an increase in serum creatinine to
300% (3-fold) from baseline or serum creatinine 354mmol/
Jung et alL (4.0mg/dL) with an acute rise of at least 44mmol/L (0.5mg/
dL) or initiation of RRT.24 All patients who met the AKIN
criteria for stages 1, 2, and 3 were considered as having AKI.
TABLE 1. Baseline Characteristics of AKI Patients and Non-AKI Pa
Total (n¼ 875) Non-AKI
Age (y) 60.5 14.6 5
Male (%) 518 (59.2) 3
Hypertension (%) 293 (33.5) 1
Diabetes mellitus (%) 155 (17.7) 1
Type of surgery
Valve surgery (%) 557 (63.7) 3
CABGþ valve surgery (%) 24 (2.7)
CABG (%) 294 (33.6) 2
Off-pump CABG (%) 263 (89.5) 2
Serum bicarbonate (mEq/L) 24.5 2.9 2
eGFR (mL/min/1.73 m2) 83.6 23.2 8
Hemoglobin (g/dL) 11.6 2.2 1
Serum glucose (mg/dL) 123.5 50.3 12
Total cholesterol (mg/dL) 154.0 38.3 15
Albumin (g/dL) 3.2 0.8
Data are expressed as either mean standard deviations or numbers (%)
AKI¼ acute kidney injury, CABG¼ coronary artery bypass graft, COPD¼
eGFR¼ estimated glomerular filtration rate.
2 | www.md-journal.comSecondary outcomes were duration of postoperative ICU stay,
total hospital stay, and in-hospital mortality.
Statistical Analysis
All statistical analyses were performed using SPSS for
Windows version 20.0 (SPSS Inc, Chicago). Continuous vari-
ables were expressed as mean standard deviation, and categ-
orical variables as absolute number with percentages.
Comparisons between the groups were made by way of analysis
of variance or Student’s t-test for continuous variables and by
the chi-squaretest or Fisher’s exact test for categorical variables.
The Kolmogorov–Smirnov test was performed to determine the
normality of the distribution of parameters. If the resulting data
did not show a normal distribution, geometric mean standard
deviation was reported; the Mann–Whitney U test or Kruskal–
Wallis test was used for multiple comparisons. Multivariate
logistic regression analysis was performed to identify indepen-
dent predictors of CSA-AKI. P values <0.05 were considered
statistically significant.
RESULTS
Patient Characteristics
Baseline clinical characteristics and laboratory findings
are shown in Table 1. The mean age was 60.5 years, and 518
patients (59.2%) were men. Among 875 patients, 155 (17.7%)
had diabetes and 294 (33.6%) underwent CABG. Of the patients
who underwent CABG, 89.5% underwent off-pump bypass
surgery. Twenty-four (2.7%) patients received simultaneous
CABG and valve operations. The mean preoperative serum
bicarbonate level was 24.5 2.9mEq/L, and the mean eGFR
before operation was 83.6 23.2mL/min/1.73m2.
Medicine  Volume 95, Number 13, April 2016Outcomes
AKI was observed in 228 patients (26.1%) after operation.
Of patients diagnosed with CSA-AKI, RRT was required in 27
tients
Patients (n¼ 647) AKI Patients (n¼ 228) P Value
9.3 14.8 63.9 13.6 <0.001
85 (59.5) 133 (58.3) 0.76
93 (29.8) 100 (43.9) <0.001
03 (15.9) 52 (22.8) 0.02
97 (61.4) 160 (70.2) 0.44
16 (2.5) 8 (3.5) 0.20
34 (36.2) 60 (26.3) 0.22
13 (91.0) 50 (83.3) 0.08
4.8 2.6 23.6 3.4 <0.001
7.7 20.3 71.9 26.6 <0.001
1.8 2.2 11.1 2.2 <0.001
3.6 46.0 130.6 60.8 0.12
.70 38.5 142.5 35.1 0.001
3.2 0.8 3.2 0.8 0.21
, except where noted.
chronic obstructive pulmonary disease, CKD¼ chronic kidney disease,
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 3. AKI Stage and Serum Bicarbonate Levels Group
Group 1
(n¼ 193)
Group 2
(n¼ 226)
Group 3
(n¼ 456)
P
Value
AKI (%) 79 (40.9) 60 (26.5) 89 (19.5) <0.001
Stage I (%) 57 (29.5) 46 (20.4) 70 (15.4) 0.61
Stage II (%) 6 (3.1) 10 (4.4) 12 (2.6) 0.25
Stage III (%) 16 (8.3) 4 (6.7) 7 (7.9) 0.02
Data are expressed as numbers (%).
Group 1 (below normal levels) <23mEq/L; group 2 (normal levels)
23–24mEq/L; group 3 (elevated levels) >24mEq/L; Acute Kidney
Network (AKIN) criteria stage 1; an increase in serum creatinine 
26.5mmol/L ( 0.3mg/dL) or increase to  150–199% (1.5- to 1.9-
fold) from baseline, Stage 2; an increase in serum creatinine to 200–
299% (>2- to 2.9-fold) from baseline, Stage 3; an increase in serum
creatinine to  300% ( 3-fold) from baseline or serum creatinine
354mmol/L ( 4.0mg/dL) with an acute rise of at least 44mmol/L
Serum Bicarbonate Predicts CSA-AKI(3.1%). Operation-related death occurred in 29 patients (3.3%).
The mean duration of postoperative ICU stay was 3.6 days, and
the mean total hospital stay duration was 19.4 days.
Comparison Between Patients With AKI and
Patients Without AKI
Compared with the non-AKI group, both mean age
(63.9 13.6 vs 59.3 14.8 years, P< 0.001) and proportion
of patients with hypertension (43.9 vs 29.8%, P< 0.001) were
significantly higher in patients with CSA-AKI. Diabetes melli-
tus was also significantly more prevalent in the AKI group (22.8
vs 15.9%, P¼ 0.02). In addition, the proportion of patients who
underwent valve replacement operation alone was significantly
higher, whereas the proportion of patients who received either
CABG alone or simultaneous valve replacement and CABG
was significantly lower in the AKI group (P¼ 0.02). Laboratory
test results revealed that serum bicarbonate levels (23.6 3.4 vs
24.8 2.6mEq/L, P< 0.001), eGFR (71.9 26.6 vs
87.7 20.3mL/min/1.73m2, P< 0.001), and hemoglobin
(11.1 2.2 vs 11.8 2.2 g/dL, P< 0.001) and serum total
cholesterol concentrations (142.5 35.1 vs 157.0 38.5mg/
dL, P< 0.001) were significantly lower in patients with AKI.
However, serum glucose and albumin levels were comparable
between the 2 groups (Table 1).
Regarding clinical outcome, the mean durations of not
only postoperative ICU stay (6.2 8.5 vs 2.7 2.2 days,
P< 0.001) but also total hospital stay (28.9 26.5 vs
16.0 14.7 days, P< 0.001) were significantly longer in
patients with CSA-AKI. Moreover, a significantly higher num-
ber of deaths (8.8 vs 1.4%, P< 0.001) was observed in the AKI
group (Table 2).
Effect of Preoperative Serum Bicarbonate Levels
on Clinical Outcome
To investigate the effect of serum bicarbonate concen-
trations on clinical outcome, patients were divided into 3 groups
according to preoperative serum bicarbonate levels: group 1
(below normal levels)< 23mEq/L; group 2 (normal levels) 23
to 24mEq/L; and group 3 (elevated levels) >24mEq/L. The
groups consisted of 193, 226, and 456 patients, respectively.
CSA-AKI developed in 40.9% of patients in group 1,
26.5% in group 2, and 19.5% in group 3. The incidences of
AKIN criteria stages 1 and 2 were comparable among the
groups, but stage 3 AKI was more common in group 1 compared
Medicine  Volume 95, Number 13, April 2016to groups 2 and 3 (P¼ 0.02). AKI events were observed more
significantly in group 1 compared with groups 2 and 3
(P¼ 0.001 and P< 0.001, respectively) (Table 3). Compared
TABLE 2. Comparison of Postoperative ICU Stay, Hospital
Stay, and Mortality for AKI Patients and Non-AKI Patients
Non-AKI
(n¼ 647)
AKI
(n¼ 228)
P
Value
Postoperative ICU stay (day) 2.7 2.2 6.2 8.5 <0.001
Hospital stay (day) 16.0 14.7 28.9 26.5 <0.001
Mortality (%) 9 (1.4) 20 (8.8) <0.001
Data are expressed as either mean standard deviations or numbers
(%), except where noted.
AKI¼ acute kidney injury, ICU¼ intensive care unit.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.with group 2 (3.61 4.3 days) and group 3 (3.30 4.3 days),
furthermore, the duration of postoperative ICU stay was sig-
nificantly longer for patients in group 1 (4.42 5.2 days)
(P¼ 0.001 and P< 0.001, respectively) (Figure 1A). Total
hospital admission duration was also significantly longer for
patients in group 1 (P< 0.001) (Figure 1B). Kaplan–Meier
cumulative survival analysis revealed that the occurrence rate of
CSA-AKI was significantly higher in group 1 compared to
groups 2 and 3 (P< 0.001) (Figure 2).
Predictors of AKI
Potential risk factors for CSA-AKI were first determined
by univariate logistic regression analysis. Patients in group 1
(OR 2.86, 95% CI 1.98–4.13, P< 0.001) and group 2 (OR 1.49,
95% CI 1.02–2.17, P¼ 0.04) were demonstrated to have sig-
nificantly higher risk of developing AKI compared with group 3
patients, suggesting that low preoperative serum bicarbonate
concentrations increased the risk of AKI after cardiac surgery.
Older age (OR 1.02, 95% CI 1.01–1.04, P< 0.001), hyperten-
sion (OR 1.84, 95%CI 1.35–2.51, P< 0.001), and diabetes (OR
1.56, 95% CI 1.07–2.27, P¼ 0.02) were also significantly
associated with the development of AKI. Moreover, valve
replacement surgery increased the risk of postoperative AKI
relative to CABG (OR 1.57, 95% CI 1.12–2.20, P¼ 0.01). In
contrast, increases in the hemoglobin level (OR 0.86, 95% CI
0.80–0.93, P< 0.001) and high eGFR (OR 0.97, 95% CI 0.96–
0.98, P< 0.001) were found to reduce the risk of development
of AKI (Table 4).
Multivariate logistic regression analysis revealed that
patients in group 1 (OR 2.36, 95% CI 1.57–3.54, P< 0.001)
and group 2 (OR 1.54, 95% CI 1.03–2.26, P¼ 0.03) were still
at increased risk of postoperative AKI even after adjustment
for confounding factors, further implying that low serum
bicarbonate concentrations may be independently
associated with a decline in renal function after cardiac surgery
(Table 5). Similarly, even after propensity score matching, a
significant increase in the risk for CSA-AKI development still
persisted in group 1 (OR 5.77, 95% CI 2.01–16.55, P< 0.001)
(0.5mg/dL) or initiation of RRT.and group 2 (OR 4.07, 95% CI 1.48–11.18, P¼ 0.01) compared
to group 3. (Supplementary Tables 1 and 2, http://links.
lww.com/MD/A857.)
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observational study, too, found that lower serum bicarbonate
concentrations predicted the development of AKI and that
mechanical ventilation was required more frequently in
par
an
TABLE 4. Univariate Logistic Regression Analysis of Cardiac
Surgery-Associated AKI Development With Clinical and Bio-
chemical Variables
OR 95% CI P Value
Jung et al Medicine  Volume 95, Number 13, April 2016DISCUSSION
Even though acidosis has been considered to be a risk
factor for renal function decline in patients with CKD, little is
known about acidosis’s association with the development of
AKI after cardiac surgery. The present study shows that slightly
lower than normal serum bicarbonate levels are associated with
consecutive diminished kidney function and adverse outcome in
patients undergoing cardiac surgery.
AKI is a common complication of cardiac surgery.
Previous studies have demonstrated that AKI is accompanied
in almost 30% of patients who have undergone cardiac
surgery—even though the incidence of CSA-AKI varies some-
what depending on the characteristics of the study popu-
lation.6,25–27 The incidence of AKI in this study was
comparable to incidences found in earlier studies. However,
the proportion of patients requiring RRT was slightly higher
than the proportions in previous investigations,3,28 which could
be attributed to a relatively higher proportion of valvular
surgery cases. Furthermore, recently easier accessibility of
continuous RRT might be partly accountable for the increase
in the number of patients with AKI who receive RRT after
FIGURE 1. Duration of postoperative ICU and hospital stay. Com
duration among preoperative serum bicarbonate level groups. Me
ICU¼ intensive care unit.cardiac operations.
CSA-AKI is known to be associated with mortality and
morbidities, including postoperative complications and
FIGURE 2. Kaplan–Meier plots for CSA-AKI according to preo-
perative serum bicarbonate levels. The log-rank test revealed that
the occurrence rate of CSA-AKI was significantly higher in group 1
compared to groups 2 and 3. z; P<0.001 vs group 1. AKI¼ acute
kidney injury, CSA-AKI¼ cardiac surgery-associated AKI.
4 | www.md-journal.cominfection.3,6,7 In accordance with previous studies, postopera-
tive ICU stay and total hospital admission durations were
significantly longer for patients who experienced CSA-AKI.
In addition, overall postoperative mortality rates were signifi-
cantly higher in the CSA-AKI group. Meanwhile, the durations
of ICU stay and hospital admission were significantly longer in
patients with lower preoperative serum bicarbonate concen-
trations. Based on those findings, it could be inferred that low
serum bicarbonate levels affected the development of CSA-
AKI, which might have led to worse clinical outcomes. A recent
ison of (A) postoperative ICU stay duration and (B) hospital stay
 standard error. P<0.05. yP<0.01. AKI¼ acute kidney injury,Serum bicarbonate
Group 1 2.86 1.98–4.13 <0.001
Group 2 1.49 1.02–2.17 0.04
Group 3 Reference
Age (per 1-year increase) 1.02 1.01–1.04 <0.001
Male (vs female) 1.05 0.77–1.05 0.76
Hypertension 1.84 1.35–2.51 <0.001
Diabetes mellitus 1.56 1.07–2.27 0.02
Operation type
CABG Reference
Valve surgery 1.57 1.12–2.20 0.01
CABGþ valve surgery 1.95 0.80–1.77 0.14
Hemoglobin (per 1-g/dL
increase)
0.86 0.80–0.93 <0.001
eGFR (per mL/min/1.73 m2
increase)
0.97 0.96–0.98 <0.001
Group 1 (below normal levels) <23mEq/L; group 2 (normal levels)
23–24mEq/L; group 3 (elevated levels) >24mEq/L.
AKI¼ acute kidney injury, CABG¼ coronary artery bypass graft,
CI¼ confidence interval, eGFR¼ estimated glomerular filtration rate,
OR¼ odds ratio.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 5. Multivariate Logistic Regression Analysis of Association Between Serum Bicarbonate Level Groups and Cardiac Surgery-
Associated AKI Development
Model 1 Model 2 Model 3
OR 95% CI P Value OR 95% CI P Value OR 95% CI P Value
Serum bicarbonate
Group 1 2.64 1.82–3.84 <0.001 2.57 1.76–3.74 <0.001 2.36 1.57–3.54 <0.001
Group 2 1.46 1.01–2.13 0.04 1.47 1.00–2.14 0.04 1.54 1.03–2.26 0.03
Group 3 Reference Reference Reference
Group 1 (below normal levels) <23mEq/L; group 2 (normal levels) 23–24mEq/L; group 3 (elevated levels) >24mEq/L.
Model 1: Adjusted for age and sex.
Model 2: Model 1 plus hypertension, diabetes mellitus.
Model 3: Model 2 plus operation type, hemoglobin, eGFR.
.
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association between the serum bicarbonate levels and renal
dysfunctions as well as the long durations of ICU stay and
hospital admission that were observed in the present study.
Several risk factors have been previously verified to be
closely associated with the development of CSA-AKI. Previous
studies showed that a variety of comorbidities such as hyper-
tension, diabetes, and underlying renal insufficiency were
implicated in AKI development after cardiac surgery.2,6,30–33
Moreover, the types of cardiac operations also were demon-
strated to be associated with CSA-AKI. Compared with off-
pump CABG, cardiac surgery using cardiopulmonary bypass
circuit increases the risk of CSA-AKI,34,35 and thus patients
receiving cardiac valve surgery have higher incidences of
postoperative AKI than do those undergoing off-pump CABG
operations.36 Consistent with the results of previous studies, we,
too, found that hypertension, diabetes, low eGFR, and valvular
heart surgery were associated with CSA-AKI. In contrast,
patients who received combined valve and CABG operation
were not at significantly higher risk of AKI, which may be
because of an extremely small number of patients undergoing
combined surgeries. Similarly, because CABG was performed
by an off-pump method in most of the patients, the difference in
the incidence of AKI between CABG patients by cardiopul-
monary bypass and by off-pump did not reach statistical
significance.
The underlying exact mechanism for the association
between low serum bicarbonate concentrations and CSA-AKI
is not clear, but several possibilities can be considered on the
basis of the results of previous animal experiments. Metabolic
acidosis has been shown to induce medullary ammonia pro-
duction, which in turn activates the alternative complement
pathway and aggravates tubular inflammation in an animal
model of AKI.37 Furthermore, excessive acid loading in mice
resulted in activation of the intrarenal rennin–angiotensin–
aldosterone system.14 In addition, sodium bicarbonate is
demonstrated to increase renal medullary oxygen delivery
and to reduce renal iron-mediated free-radical formation.38
Based on those findings, some investigators attempted to pre-
vent AKI through urine alkalization by sodium bicarbonate
infusion, but the results of those trials were inconsistent.39,40
AKI¼ acute kidney injury, CI¼ confidence interval, OR¼ odds ratioThe results of the present study could aid in the selection of
patients at high risk of AKI, and such therapeutic interventions
might be of benefit to them.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.There is a possibility that the serum carbon dioxide levels
may not represent the true serum bicarbonate concentrations in
conditions such as respiratory alkalosis or sepsis. Comorbid
conditions of the studied patients were re-examined to inves-
tigate the probable consequence of serum carbon dioxide
change due to these disorders. None of the patients had active
infection including sepsis. In addition, chronic obstructive
pulmonary disease and heart failure were accompanied in
5.4% and 19.4% of the patients, respectively, but the prevalence
of these comorbidities was comparable among the 3 groups
(Supplementary Table 3, http://links.lww.com/MD/A857).
Moreover, when additional analysis was done with 191 patients
in whom arterial blood gas analysis (ABGA) was done at the
same time of serum bicarbonate level test, only 6 patients were
found to have respiratory alkalosis (result not shown). Further-
more, the low serum bicarbonate level was still a significant
predictor of CSA-AKI even in analyses excluding these patients
(Supplementary Table 4, http://links.lww.com/MD/A857).
Similarly, even after propensity score matching, a significant
increase in the risk for CSA-AKI development still persisted in
groups 1 and 2 compared to group 3. Therefore, low serum
bicarbonate levels due to low carbon dioxide levels may have
little impact on the final results of the study.
There are a number of limitations in this study. First, even
though limitation in patient selection is inevitable because of the
retrospective design, all patients who underwent cardiac surgery
during the given study period were included in the analysis in
order to minimize selection bias. In addition, because the
patients underwent heart operations in a single center, most
of the operation-procedure-related factors as well as postopera-
tive management practice were surmised to be controlled
appropriately. Second, ABGA results were not available in
all of the patients. Arterial pCO2 and pH were not determined,
thereby opening the possibility that some of the alteration in
serum bicarbonate levels could be a consequence of respiratory
problems. Third, the serum bicarbonate levels used in our study
were values from a single-time-point. Serum bicarbonate levels
could fluctuate overtime. Considering that the mean interval
between serum bicarbonate level measurement and operation
was about 1 day (mean 24.9 13.2 hours) the possibility of a
large level change may not be great. To validate whether serum
bicarbonate levels were stable or not during a short time period,
152 patients in whom repeated measurements of serum
bicarbonate were done within 96 hours before operation were
www.md-journal.com | 5
re-evaluated. In result, we found that there was a significantly
close correlation between the mean levels of serum bicarbonate
of each patients during the 96 hours and the bicarbonate levels
used in the present study (R¼ 0.856, P< 0.001). In addition, the
serum bicarbonate group was changed during the 96 hours in
only 2 patients. Nonetheless, the chance of misgrouping due to
bicarbonate value fluctuation could not be completely excluded.
Fourth, the number of patients was relatively small. Despite
some aforementioned weak points, the results of the study found
that serum bicarbonate concentrations were significantly
associated with an increase in the risk of CSA-AKI regardless
of the etiology of lower serum bicarbonate levels.
In conclusion, even slightly lower than normal serum
bicarbonate levels before cardiac operation are associated with
the development of postoperative AKI independent of baseline
eGFR and other clinical and demographic factors. Further
studies are needed to clarify whether strict correction of
bicarbonate levels close to normal limits may have a protective
role in preventing further AKI development after cardiac
surgery.
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